{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:05Z","timestamp":1789609205730,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1053\/j.ackd.2014.01.008","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T04:01:37Z","timestamp":1393905697000},"page":"217-227","source":"Crossref","is-referenced-by-count":22,"title":["Plasma Exchange for Kidney Disease: What Is the Best Evidence?"],"prefix":"10.1053","volume":"21","author":[{"given":"Ainslie M.","family":"Hildebrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-130X","authenticated-orcid":false,"given":"Shih-Han S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.1990.181","article-title":"Plasma exchange with a rotating filter","volume":"38","author":"Kaplan","year":"1990","journal-title":"Kidney Int"},{"issue":"5965","key":"10.1053\/j.ackd.2014.01.008_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bmj.2.5965.252","article-title":"Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis","volume":"2","author":"Lockwood","year":"1975","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.008_bib3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: core curriculum 2008","volume":"52","author":"Kaplan","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2014.01.008_bib4","unstructured":"Canadian Apheresis Group Data Reports. Paper presented at: Canadian Apheresis Group 2013 Annual General Meeting; April 12-14, 2013; Winnipeg, Manitoba, Canada."},{"issue":"6","key":"10.1053\/j.ackd.2014.01.008_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-131-6-199909210-00011","article-title":"Therapeutic plasma exchange: an update from the Canadian Apheresis Group","volume":"131","author":"Clark","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1053\/j.ackd.2014.01.008_bib7","first-page":"139","article-title":"KDIGO Clinical Practice Guideline for glomerulonephritis","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"20","key":"10.1053\/j.ackd.2014.01.008_bib8","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.94.1.35","article-title":"A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah","volume":"94","author":"Siegler","year":"1994","journal-title":"Pediatrics"},{"key":"10.1053\/j.ackd.2014.01.008_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pathmechdis.3.121806.154311","article-title":"Pathogenesis of thrombotic microangiopathies","volume":"3","author":"Zheng","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.1987.206","article-title":"HUS and TTP: variable expression of a single entity","volume":"32","author":"Remuzzi","year":"1987","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine (Baltimore)"},{"issue":"22","key":"10.1053\/j.ackd.2014.01.008_bib13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.008_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1053\/j.ackd.2014.01.008_bib16","first-page":"1761","volume":"20","author":"Henon","year":"1991","journal-title":"Presse Med"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib17","first-page":"CD003595","article-title":"Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura","author":"Michael","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2008.07.038","article-title":"Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials","volume":"53","author":"Michael","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2141.2008.07317.x","article-title":"Treating TTP\/HUS with plasma exchange: a single centre's 25-year experience","volume":"143","author":"Forzley","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-3148.2006.00720.x","article-title":"A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura","volume":"17","author":"Brunskill","year":"2007","journal-title":"Transfus Med"},{"key":"10.1053\/j.ackd.2014.01.008_bib21","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/ki.2008.621","article-title":"TTP\/HUS: observational studies generate hypotheses that lead to randomized controlled trials","volume":"112","author":"Clark","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1537-2995.2007.01530.x","article-title":"Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006","volume":"48","author":"Nguyen","year":"2008","journal-title":"Transfusion"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0032-1333538","article-title":"Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia","volume":"39","author":"George","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jca.21221","article-title":"Plasma exchange for renal disease: evidence and use 2011","volume":"27","author":"Clark","year":"2012","journal-title":"J Clin Apher"},{"issue":"10","key":"10.1053\/j.ackd.2014.01.008_bib25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.ackd.2014.01.008_bib26","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Clinical Practice Guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2004.10.018","article-title":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15","volume":"45","author":"Licht","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.ackd.2014.01.008_bib32","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1523-1755.2003.00241.x","article-title":"Anti-glomerular basement membrane disease","volume":"64","author":"Pusey","year":"2003","journal-title":"Kidney Int"},{"issue":"26","key":"10.1053\/j.ackd.2014.01.008_bib34","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","article-title":"Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV","volume":"263","author":"Saus","year":"1988","journal-title":"J Biol Chem"},{"issue":"6516","key":"10.1053\/j.ackd.2014.01.008_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmj.292.6516.301","article-title":"Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4","volume":"292","author":"Savage","year":"1986","journal-title":"BMJ"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.1973.14","article-title":"Anti-glomerular basement membrane antibody-induced glomerulonephritis","volume":"3","author":"Wilson","year":"1973","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","article-title":"Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1053\/j.ackd.2014.01.008_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ackd.2014.01.008_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"150","author":"De Groot","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.008_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib44","first-page":"1","article-title":"Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study","volume":"29","author":"Gl\u00f6ckner","year":"1988","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey","year":"1991","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(12)80699-8","article-title":"A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group","volume":"20","author":"Cole","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ackd.2014.01.008_bib47","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2014.01.008_bib48","first-page":"493","article-title":"Treatment of idiopathic acute crescentic glomerulonephritis by immunodepression and plasma-exchanges. A prospective randomised study","volume":"18","author":"Rifle","year":"1981","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1053\/j.ackd.2014.01.008_bib49","first-page":"587","article-title":"Therapeutic plasma exchange in the treatment of rapidly progressive glomerulonephritis","volume":"6","author":"Mauri","year":"1985","journal-title":"Plasma Ther Transfus Technol"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib50","first-page":"198","article-title":"Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis","volume":"148","author":"Guillevin","year":"1997","journal-title":"Ann Med Interne (Paris)"},{"issue":"11","key":"10.1053\/j.ackd.2014.01.008_bib51","first-page":"A1","article-title":"Long term outcome and prognostic factors in randomized study of plasma exchange and cyclosporine A in Wegeners granulomatosis","volume":"10","author":"Szpirt","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2014.01.008_bib52","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","article-title":"Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear","volume":"84","author":"Walsh","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2014.01.008_bib54","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1681\/ASN.2007050575","article-title":"Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis","volume":"18","author":"Lionaki","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2014.01.008_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","article-title":"Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial","volume":"14","author":"Walsh","year":"2013","journal-title":"Trials"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.008_bib56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib57","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ackd.2014.01.008_bib58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/ard.57.12.701","article-title":"Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity","volume":"57","author":"Agnello","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1526-0968.2002.00400.x","article-title":"Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases","volume":"6","author":"Dominguez","year":"2002","journal-title":"Ther Apher"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2010.03.001","article-title":"Plasma exchange for treating cryoglobulinemia: a descriptive analysis","volume":"42","author":"Rockx","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.008_bib61","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.008_bib62","first-page":"287","article-title":"Acute renal failure in essential mixed cryoglobulinemia: precipitation and reversal by plasma exchange","volume":"21","author":"Evans","year":"1984","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.008_bib64","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2215\/CJN.06170613","article-title":"Is there clinical value in measuring suPAR levels in FSGS?","volume":"8","author":"Sever","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.008_bib65","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.008_bib66","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report","volume":"8","author":"Bock","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jca.10007","article-title":"Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: re-analysis of published case-reports and case-series","volume":"16","author":"Davenport","year":"2001","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib68","first-page":"271","article-title":"Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients","volume":"56","author":"Matalon","year":"2001","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.008_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1432-2277.2004.tb00420.x","article-title":"Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant","volume":"17","author":"Deegens","year":"2004","journal-title":"Transpl Int"},{"issue":"suppl 3","key":"10.1053\/j.ackd.2014.01.008_bib70","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"issue":"23","key":"10.1053\/j.ackd.2014.01.008_bib71","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2014.01.008_bib72","unstructured":"2011 OPTN\/SRTR Annual Report: transplant data 2001-2011. Available at: www.ustransplant.org. Accessed November\u00a018, 2013."},{"issue":"2","key":"10.1053\/j.ackd.2014.01.008_bib73","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.008_bib74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"issue":"10","key":"10.1053\/j.ackd.2014.01.008_bib75","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00007890-200011270-00023","article-title":"A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants","volume":"70","author":"Schweitzer","year":"2000","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib76","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1600-6143.2004.00364.x","article-title":"Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers","volume":"4","author":"Warren","year":"2004","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.008_bib78","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: diagnosis and pathogenesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trre.2008.08.004","article-title":"Antibody-mediated rejection: treatment alternatives and outcomes","volume":"23","author":"Singh","year":"2009","journal-title":"Transplant Rev"},{"issue":"11","key":"10.1053\/j.ackd.2014.01.008_bib80","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00147-003-0658-3","article-title":"Diagnosis and treatment of antibody-mediated kidney allograft rejection","volume":"16","author":"B\u00f6hmig","year":"2003","journal-title":"Transpl Int"},{"issue":"9","key":"10.1053\/j.ackd.2014.01.008_bib81","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.transproceed.2005.09.128","article-title":"Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation","volume":"37","author":"Ibern\u00f3n","year":"2005","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-0012.2004.00296.x","article-title":"Novel rescue therapy for C4d-positive acute humoral renal allograft rejection","volume":"19","author":"Min","year":"2005","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2014.01.008_bib83","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.tp.0000261113.30757.d1","article-title":"Rituximab therapy for acute humoral rejection after kidney transplantation","volume":"83","author":"Faguer","year":"2007","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.008_bib84","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.TP.0000128194.55934.48","article-title":"Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection","volume":"78","author":"White","year":"2004","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.008_bib85","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1600-6143.2009.02591.x","article-title":"Comparison of combination Plasmapheresis\/IVIg\/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection","volume":"9","author":"Lefaucheur","year":"2009","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2014.01.008_bib86","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.transproceed.2009.06.197","article-title":"Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation","volume":"41","author":"Brown","year":"2009","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1053\/j.ackd.2014.01.008_bib87","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ackd.2014.01.008_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00270299","article-title":"The nonspecific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis","volume":"5","author":"L\u00f6w","year":"1985","journal-title":"Rheumatol Int"},{"key":"10.1053\/j.ackd.2014.01.008_bib89","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1526-0968.2001.00386.x","article-title":"Plasmapheresis affects T helper type-1\/T helper type-2 balance of circulating peripheral lymphocytes","volume":"5","author":"Goto","year":"2001","journal-title":"Ther Apher"},{"issue":"10","key":"10.1053\/j.ackd.2014.01.008_bib90","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM197903083001003","article-title":"Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange","volume":"300","author":"Lockwood","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2014.01.008_bib91","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1592\/phco.27.11.1529","article-title":"Drug removal by plasmapheresis: an evidence-based review","volume":"27","author":"Ibrahim","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ackd.2014.01.008_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jca.21261","article-title":"Medications and therapeutic apheresis procedures: are we doing our best?","volume":"28","author":"Ibrahim","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1053\/j.ackd.2014.01.008_bib93","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1525-139X.2011.01030.x","article-title":"Medications in patients treated with therapeutic plasma exchange: prescription dosage, timing, and drug overdose","volume":"25","author":"Ibrahim","year":"2013","journal-title":"Semin Dial"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.008_bib94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/ajkd.2002.29874","article-title":"Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis","volume":"39","author":"Z\u00e4uner","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2014.01.008_bib95","first-page":"402","article-title":"Removal of prednisone and prednisolone by plasma exchange","volume":"3","author":"Stigelman","year":"1984","journal-title":"Clin Pharm"},{"key":"10.1053\/j.ackd.2014.01.008_bib96","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1526-0968.2001.00383.x","article-title":"Therapeutic plasma exchange in the intensive care setting","volume":"5","author":"Samtleben","year":"2001","journal-title":"Ther Apher"},{"key":"10.1053\/j.ackd.2014.01.008_bib97","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/RLNM-J01W-BJRN-LH03","article-title":"Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP","volume":"125","author":"Darabi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.ackd.2014.01.008_bib98","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2141.2004.04836.x","article-title":"Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature","volume":"124","author":"Yomtovian","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ackd.2014.01.008_bib99","series-title":"Lexi-Comp OnlineTM","year":"2014"},{"key":"10.1053\/j.ackd.2014.01.008_bib100","first-page":"29","article-title":"The pharmacokinetics of anti-thymocyte globulin (ATG) following intravenous infusion in man","volume":"45","author":"Bunn","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2014.01.008_bib101","series-title":"Soliris\u00ae (eculizumab) [package insert]","year":"2011"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559514000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559514000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T19:27:06Z","timestamp":1716578826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559514000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1548559514000111"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2014.01.008","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}